(HealthDay)—Primary care physicians are more or less likely to prescribe long-acting reversible contraception such as intrauterine devices (IUDs) to adolescents based on their knowledge, skills, clinical environment, and ...
Mar 29, 2013
0
0
A French drug watchdog on Tuesday released estimates for blood clots linked to birth control pills in the wake of fears that so-called third- and fourth-generation oral contraceptives boost a small risk of dangerous thrombosis.
Mar 26, 2013
0
0
Women reaching the age of 40 tend to be less vigilant about birth control because they think the risk of pregnancy is low – or that birth control can cause health problems - but a review of the evidence by a team that includes ...
Mar 25, 2013
0
0
New research on contraceptive prevalence and unmet need for contraception in married or co-habiting women of reproductive age (15 – 49 years), based on data from 194 countries, suggests that although the proportion of women ...
Mar 11, 2013
0
0
More consistent use of condoms, oral contraception or both was reported by a group of teenage girls who took part in a youth development intervention aimed at reducing pregnancy risk in high-risk adolescents, according to ...
Feb 25, 2013
0
0
Boosting demand for intrauterine devices, commonly referred to as IUDs, and improving access to them can significantly increase their use in developing countries, where they have traditionally been an unpopular method of ...
Feb 15, 2013
0
0
(HealthDay)—The number of U.S. women using the "morning-after" contraception pill has risen dramatically in the last decade, federal health officials report.
Feb 14, 2013
0
0
Parents are more accepting of their teenage daughters using birth control pills than any other form of contraception, including condoms, according to a recent study from UC San Francisco (UCSF).
Feb 12, 2013
0
0
A first-of-its-kind study by researchers at the Keck School of Medicine of the University of Southern California (USC) indicates that healthy, obese, reproductive-age women who use long-acting reversible contraception (LARC) ...
Feb 7, 2013
0
1
(HealthDay)—Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune response, according ...
Feb 1, 2013
0
0
